Activest Wealth Management Galectin Therapeutics Inc Transaction History
Activest Wealth Management
- $347 Million
- Q1 2025
A detailed history of Activest Wealth Management transactions in Galectin Therapeutics Inc stock. As of the latest transaction made, Activest Wealth Management holds 2,000 shares of GALT stock, worth $4,840. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,000
Previous 2,000
-0.0%
Holding current value
$4,840
Previous $2,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding GALT
# of Institutions
103Shares Held
10.1MCall Options Held
587KPut Options Held
2.02M-
Vanguard Group Inc Valley Forge, PA2.19MShares$5.31 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.56MShares$3.78 Million0.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ1.22MShares$2.96 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA853KShares$2.06 Million0.0% of portfolio
-
Geneos Wealth Management Inc.423KShares$1.02 Million0.02% of portfolio
About GALECTIN THERAPEUTICS INC
- Ticker GALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,426,000
- Market Cap $144M
- Description
- Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial f...